Pharmaceuticals & Therapeutics

Biotech firm AstronauTx appoints a new CMO and VP, signaling a pivotal move to clinical trials for its novel Alzheimer's therapy targeting sleep architecture.

Javier Vasquez of Miguel's Restaurants joins the LLUCH Foundation board, blending a 50-year family legacy with a new era of strategic philanthropy.

With two pivotal trial readouts looming and cash projected to last only into Q4, Tvardi Therapeutics faces a make-or-break year for its STAT3 inhibitors.

As Talphera preps its Q1 update, all eyes are on its breakthrough drug Niyad® and the mounting costs of bringing a potential game-changer to market.

After 40 years, capsule giant CapsCanada becomes Lyfe Group, a strategic move to unify its brand, leverage new investments, and lead the drug delivery market.

Vancouver's ME Therapeutics will unveil its in-vivo immune reprogramming technology, a potential cancer treatment game-changer, to global investors.

A massive $250M investment could replace a 40-pill daily burden with a single tablet for patients with pancreatic insufficiency, disrupting a market in crisis.

A landmark European trial for a new genomic test has passed 50% recruitment, promising to tailor breast cancer therapy and improve patient quality of life.

Fueled by a $100M R&D investment, Chinese beauty giant Yatsen is leading a market shift from price wars to scientific innovation, winning global consumers.

The diagnostics firm's stellar quarter is fueled by surging test volumes and a new non-invasive prenatal test poised to disrupt high-risk screening.

As Walmart Canada launches its annual campaign for kids' health, a look at how decades of donations address critical gaps in a strained medical system.

Diathrive Health and AliveCor's KardiaComplete partner to offer an integrated solution for diabetes and heart disease, combating fragmented care and rising costs.

Co-founded by Maria Shriver, MOSH raises $13M to scale its brain health nutrition brand, targeting a national grocery and Target rollout.

Pet Honesty launches "The Honest Difference," a new standard for supplement transparency, and pledges a $1M product donation to pets in need.

RVL Pharmaceuticals claims double-digit growth for its eye drop Upneeq, but as a private firm, its disruptive direct-to-consumer model operates outside public view.

A new global partnership aims to solve key bottlenecks in regenerative medicine by providing standardized, high-quality umbilical cord stem cells to researchers.

Alcami acquires Tjoapack, creating a transatlantic CDMO. The deal, orchestrated by owner Ampersand Capital, signals a major shift in pharma services.

The Sugar Ray Leonard Foundation's 15th annual charity boxing night will honor Dr. Jennifer Raymond for her groundbreaking work in pediatric diabetes care.

Medical tech giant Convatec unveils a new arsenal of advanced wound care solutions, using nitric oxide and placental tech to combat hard-to-heal injuries.

Sensei Biotherapeutics begins a key trial for PIKTOR, a novel oral therapy aiming to outsmart cancer resistance in patients with advanced breast cancer.